Carbon monoxide can prevent acute lung injury observed after ischemia reperfusion of the lower extremities

J Surg Res. 2007 Dec;143(2):437-42. doi: 10.1016/j.jss.2007.02.013. Epub 2007 Sep 7.

Abstract

Background: Pulmonary expression of heme oxygenase has been observed in multiple studies. This expression has been found beneficial in decreasing the severity of acute lung injury (ALI) post ischemia-reperfusion (I/R). The aim of this study was to assess the role of exogenous administration of the end-products of heme oxygenase reaction, carbon monoxide, and bilirubin, in the severity of ALI.

Study design: We compared five groups of rats (n = 7/group) including a sham group and four I/R of the lower extremities by clamping the abdominal aorta for 2 h followed by reperfusion for 2 h. The four I/R groups included a control group, one pretreated with bilirubin (50 micromol/kg IV), another with inhaled carbon monoxide (CO) (250 ppm), and the last pretreated with both. The severity of ALI has been evaluated by a histological assay grading neutrophilic infiltration, as well as a study of the microvascular permeability using the Evans blue.

Results: The administration of CO prevented pulmonary microvascular permeability alteration noted after I/R of the lower limbs (pulmonary content of Evans blue: 141 +/- 23 microg/g of tissue in the isolated I/R group versus 68 +/- 34 microg/g of tissue in CO group; P < 0.001). Histologically CO administration inhibited neutrophilic sequestration observed after I/R. On the other hand, treatment by bilirubin alone (50 micromol/kg IV) did not modify the extent of pulmonary injury.

Conclusion: Exogenous administration of carbon monoxide by inhalation at low doses prevented ALI post-I/R in this model.

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Antimetabolites / pharmacology*
  • Bilirubin / pharmacology
  • Blood Pressure
  • Carbon Monoxide / pharmacology*
  • Coloring Agents / pharmacokinetics
  • Disease Models, Animal
  • Drug Therapy, Combination
  • Evans Blue / pharmacokinetics
  • Heme / metabolism
  • Hindlimb
  • Male
  • Pulmonary Edema / etiology
  • Pulmonary Edema / pathology
  • Pulmonary Edema / prevention & control
  • Rats
  • Rats, Wistar
  • Reperfusion Injury / complications*
  • Respiratory Distress Syndrome / etiology*
  • Respiratory Distress Syndrome / pathology
  • Respiratory Distress Syndrome / prevention & control*
  • Severity of Illness Index

Substances

  • Anti-Inflammatory Agents
  • Antimetabolites
  • Coloring Agents
  • Heme
  • Evans Blue
  • Carbon Monoxide
  • Bilirubin